In a recent study published in JAMA Oncology, researchers have discovered a potential link between oral bacteria and head and neck squamous cell cancer. Although the bacteria themselves do not cause the cancer, their presence could indicate a higher risk of up to 50%. This finding emphasizes the importance of oral health and regular dental check-ups.
On a different note, Pfizer has made a surprising decision to withdraw its sickle cell pill from the market. This move has raised questions about the implications for patients, the company, and the FDA.
In other news, the Food and Drug Administration (FDA) has announced plans to increase regulation of food additives. Currently, additives such as dyes, preservatives, and chemicals in packaging do not undergo proactive monitoring for safety. This lack of oversight has raised concerns, especially when additives are found to be unsafe but remain in use. The FDA’s pledge to ban red dye No. 3 in 1990 after it was linked to cancer in rats is an example of the agency’s delayed response to safety concerns.
In a recent discussion with D.C. officials, topics such as pandemic preparedness and Medicare reforms were addressed. Assistant Secretary Dawn O’Connell emphasized the need for nimble responses to disease outbreaks, while Senator Maggie Hassan advocated for “site neutral” reforms in Medicare payments to ensure equal reimbursement for healthcare services regardless of the care setting.
A groundbreaking discovery in human development has revealed a “pause button” that embryos can activate to enhance survival chances. This mechanism, observed in over 130 mammal species, including humans, could have significant implications for in vitro fertilization by allowing for better assessment of embryo health and improved implantation success.
Despite FDA approval, insurance coverage for gene therapy, such as Sarepta’s Elevidys for Duchenne muscular dystrophy, remains a challenge for patients like 15-year-old Sarah Jenssen. The complex process of obtaining insurance approval for expensive treatments underscores the need for improved access to innovative therapies for rare diseases.
On a lighter note, researchers have uncovered the role of neuroendocrine cells in preventing choking incidents by triggering coughing or swallowing responses. This discovery sheds light on the intricate mechanisms that safeguard our airways from foreign objects.
In a bid to combat antibiotic resistance, the Advanced Research Projects Agency for Health (ARPA-H) has awarded a $27 million grant to Phare Bio and Jim Collins’ lab at MIT/Harvard’s Wyss Institute. Using artificial intelligence, the team aims to develop new classes of antibiotics and establish an open-source database for AI-based antibiotic discovery.
Overall, the healthcare landscape is evolving with new discoveries, regulatory changes, and challenges in accessing innovative treatments. Stay informed with STAT’s latest updates and insights on health and medicine.
